Unknown

Dataset Information

0

Anti-nociceptive and Anti-inflammatory Activities of Asparacosin A Involve Selective Cyclooxygenase 2 and Inflammatory Cytokines Inhibition: An in-vitro, in-vivo, and in-silico Approach.


ABSTRACT: Triterpenes possess anti-inflammatory and anti-nociceptive effects. In this study anti-inflammatory activities of Asparacosin A were evaluated' using in-vitro cyclooxygenases 1 and 2 (COX-1/2) inhibition assays. Moreover, anti-nociceptive activities were assessed in-vivo by carrageenan-induced paw edema test, xylene-induced ear edema tests, and acetic acid-induced writhing and formalin tests. Additionally molecular docking was conducted to elucidate the binding mechanism of the compound and to correlate the in-vitro findings with the in-silico data. Oral administration of Asparacosin A at the doses of 10, 20, and 40 mg/kg induced significant anti-inflammatory effects (* p < 0.05, ** p < 0.01, and *** p < 0.001) in a dose-dependent manner in both models. Asparacosin A also inhibited the human recombinant COX-2 enzyme and caused a dose-dependent decrease in the levels of TNF-?, IL-1?, and PGE2 in the carrageenan-induced paws. Moreover, Asparacosin A displayed significant anti-nociceptive effects (* p < 0.05, ** p < 0.01, *** p < 0.001) at the doses of 10, 20, and 40 mg/kg in acetic-acid induced writhing test. However, in formalin test, Asparacosin A (10-40 mg/kg, p.o) produced anti-nociceptive effects only in the late phase, similar to the effect observed with the reference drug celecoxib (50 mg/kg, p.o). Molecular docking was carried out on both COX-1 and COX-2 structures which revealed that Asparacosin A targets allosteric binding site similar to the binding mode of the selective COX inhibitor. In conclusion, Asparacosin A exhibits anti-inflammatory and peripheral anti-nociceptive activities which are likely mediated via inhibition of COX-2 enzyme and inflammatory cytokines. Furthermore, Asparacosin A can serve as a model to obtain new and more selective potent anti-inflammatory and anti-nociceptive drugs.

SUBMITTER: Karim N 

PROVIDER: S-EPMC6443962 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-nociceptive and Anti-inflammatory Activities of Asparacosin A Involve Selective Cyclooxygenase 2 and Inflammatory Cytokines Inhibition: An <i>in-vitro, in-vivo</i>, and <i>in-silico</i> Approach.

Karim Nasiara N   Khan Inamullah I   Khan Waheed W   Khan Imran I   Khan Ajmal A   Halim Sobia Ahsan SA   Khan Hizbullah H   Hussain Javid J   Al-Harrasi Ahmed A  

Frontiers in immunology 20190326


Triterpenes possess anti-inflammatory and anti-nociceptive effects. In this study anti-inflammatory activities of Asparacosin A were evaluated' using <i>in-vitro</i> cyclooxygenases 1 and 2 (COX-1/2) inhibition assays. Moreover, anti-nociceptive activities were assessed <i>in-vivo</i> by carrageenan-induced paw edema test, xylene-induced ear edema tests, and acetic acid-induced writhing and formalin tests. Additionally molecular docking was conducted to elucidate the binding mechanism of the com  ...[more]

Similar Datasets

| S-EPMC3933800 | biostudies-literature
| S-EPMC6769720 | biostudies-literature
| S-EPMC6504711 | biostudies-other
| S-EPMC11304066 | biostudies-literature
| S-EPMC9445084 | biostudies-literature
| S-EPMC5316937 | biostudies-literature
| S-EPMC4895225 | biostudies-other
| S-EPMC4289196 | biostudies-literature
| S-EPMC6757439 | biostudies-literature
| S-EPMC3101256 | biostudies-literature